Drug Design, Development and Therapy (Jan 2017)

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials [Corrigendum]

  • Toussirot E,
  • Vauchy C,
  • Binda D,
  • Michel F

Journal volume & issue
Vol. Volume11
pp. 175 – 176

Abstract

Read online

Toussirot E, Vauchy C, Binda D, Michel F. Drug Des Devel Ther. 2016;10:2087–2094.On page 2089, a column heading in Table 1 was incorrectly presented. The last column heading was presented as “Golimumab 60 mg”, whereas this should have been presented as “Golimumab 100 mg” as shown below:Read the original article